30.06.2013 Views

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

to considerable suffering which Mike had endured during his life. <strong>How</strong>ever,<br />

much <strong>of</strong> this suffering was as a result <strong>of</strong> <strong>the</strong> epilepsy and not for <strong>the</strong> lack <strong>of</strong> <strong>the</strong><br />

drug he was applying to PHARMAC for a subsidy.<br />

Dr. Peter Moodie, <strong>the</strong> Medical Director <strong>of</strong> PHARMAC said that <strong>the</strong> Community<br />

<strong>Exceptional</strong> Circumstances policy was <strong>the</strong>re for extremely rare conditions. He<br />

said that a panel <strong>of</strong> New Zealand medical experts examined each claim and<br />

made <strong>the</strong>ir decision on a case by case basis. Moodie stated that epilepsy is not<br />

rare (i.e., 10 cases or less in New Zealand at any one time) and this is why Mike<br />

was turned down for <strong>the</strong> Community <strong>Exceptional</strong> Circumstances claim.<br />

Case 3: “King refuses to step in for drug” (Christchurch Press 05/05/04)<br />

In this story, Shirley Reid was suffering from motor neurone disease. This is a<br />

progressive degenerative neurological disease which ends in a slow and<br />

debilitating premature death. Shirley and her husband petitioned <strong>the</strong> Hon.<br />

Annette King, who was <strong>the</strong> Minister <strong>of</strong> Health at <strong>the</strong> time, to pressure<br />

PHARMAC to fund a new drug which promised to extend her life. Shirley said<br />

that <strong>the</strong> drug should also be available for o<strong>the</strong>r motor neurone disease<br />

sufferers. Shirley had been turned down for a Community <strong>Exceptional</strong><br />

Circumstances subsidy for <strong>the</strong> new drug. The panel <strong>of</strong> experts refused to<br />

recommend listing <strong>the</strong> new drug on <strong>the</strong> Community Pharmaceutical Schedule<br />

because in <strong>the</strong> committee’s opinion <strong>the</strong> cost <strong>of</strong> <strong>the</strong> new drug was too high for<br />

<strong>the</strong> limited benefit it <strong>of</strong>fered.<br />

Health Minister Hon. Annette King said that she was sympa<strong>the</strong>tic to Shirley’s<br />

plight but would not intervene in PHARMAC’s decision making. She asked <strong>the</strong><br />

patient to apply under <strong>the</strong> PHARMAC rules for a Community <strong>Exceptional</strong><br />

Circumstances subsidy. This was not good advice because she had already<br />

applied to PHARMAC for a Community <strong>Exceptional</strong> Circumstances and been<br />

turned down. The Minister was also wrong to suggest this course <strong>of</strong> action<br />

because motor neurone disease is not a rare condition, by PHARMAC’s<br />

definition <strong>of</strong> rare and such a claim would fail. Shirley’s husband expressed his<br />

outrage and frustration and powerlessness against PHARMAC. He described<br />

<strong>the</strong> PHARMAC Community <strong>Exceptional</strong> Circumstances system as ‘uncivilised’.<br />

146

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!